ArticleTranslational lung cancer research2023

Safety and feasibility of carboplatin and paclitaxel in combination with nintedanib for non-small cell lung cancer patients with idiopathic pulmonary fibrosis: a prospective pilot study.

Tomonori Makiguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.